Abbott's Libre® Technology is the first continuous glucose monitor associated with reduced hospitalizations for cardiac complications in diabetic patients
Abbott's Libre® Technology is the first continuous glucose monitor associated with reduced hospitalizations for cardiac complications in diabetic patients New data reveal a 78% reduction in cardiovascular disease-related hospitalizations in…